MiMedx appoints ex-BioTelemetry CEO Joseph H. Capper as CEO, effective Jan 27

MIMEDX GROUP, INC.

Appointed Joseph H. Capper as CEO and director, effective Jan 27, 2023; Todd Newton steps down as interim CEO but remains on board.
Capper receives $750k salary, 100% target bonus, 3.3M PSUs (4-yr vest), and option for 3.6M shares at $3.70 strike.
Capper previously led BioTelemetry, acquired by Philips for $2.8B; has ~30 years MedTech/Life Sciences experience.
Inducement PSUs and option granted outside equity plan under Nasdaq Rule 5635(c)(4).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

K. Todd Newton

Interim Chief Executive Officer

MDXG · MIMEDX GROUP, INC.

Effective: 2023-01-27
Successor: Joseph H. Capper
Filed: January 30, 2023, 6:59 PM ET

Also on January 30, 2023, the Company announced that K. Todd Newton will step down and cease to serve as Interim Chief Executive Officer of the Company, also effective on January 27, 2023, but will remain on the Board.

Appointed

Joseph H. Capper

Chief Executive Officer

MDXG · MIMEDX GROUP, INC.

Effective: 2023-01-27
Filed: January 30, 2023, 6:59 PM ET

On January 30, 2023, MiMedx Group, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has appointed Joseph H. Capper to serve as Chief Executive Officer of the Company, effective on January 27, 2023.

Appointed

Joseph H. Capper

Director

MDXG · MIMEDX GROUP, INC.

Effective: 2023-01-27
Filed: January 30, 2023, 6:59 PM ET

Mr. Capper will also be appointed to the Board of Directors effective on the commencement of his employment with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

K. Todd Newton departed as Interim Chief Executive Officer at MIMEDX GROUP, INC..

Action: stepped down
Role: Interim Chief Executive Officer

Exact text from the filing

Also on January 30, 2023, the Company announced that K. Todd Newton will step down and cease to serve as Interim Chief Executive Officer of the Company, also effective on January 27, 2023, but will remain on the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph H. Capper was appointed as Chief Executive Officer at MIMEDX GROUP, INC..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On January 30, 2023, MiMedx Group, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) has appointed Joseph H. Capper to serve as Chief Executive Officer of the Company, effective on January 27, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Joseph H. Capper was appointed as Director at MIMEDX GROUP, INC..

Action: appointed
Role: Director

Exact text from the filing

Mr. Capper will also be appointed to the Board of Directors effective on the commencement of his employment with the Company.

View on SEC.gov

MIMEDX GROUP, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-018383

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.